Pages that link to "Q39497051"

The following pages link to Resistance of colorectal cancer cells to radiation and 5-FU is associated with MELK expression (Q39497051):

Displaying 31 items.

• Maternal embryonic leucine zipper kinase (MELK): a novel regulator in cell cycle control, embryonic development, and cancer (Q27022633) (← links)
• Maternal embryonic leucine zipper kinase: key kinase for stem cell phenotype in glioma and other cancers (Q33723151) (← links)
• Maternal embryonic leucine zipper kinase enhances gastric cancer progression via the FAK/Paxillin pathway (Q33960305) (← links)
• MELK-a conserved kinase: functions, signaling, cancer, and controversy (Q35268631) (← links)
• Computational Identification of Key Regulators in Two Different Colorectal Cancer Cell Lines. (Q35993392) (← links)
• Can an IL13 -1112 C/T (rs1800925) polymorphism predict responsiveness to neoadjuvant chemoradiotherapy and survival of Chinese Han patients with locally advanced rectal cancer? (Q36014263) (← links)
• MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells (Q36275700) (← links)
• Genome-wide effects of MELK-inhibitor in triple-negative breast cancer cells indicate context-dependent response with p53 as a key determinant (Q36289944) (← links)
• Maternal embryonic leucine zipper kinase serves as a poor prognosis marker and therapeutic target in gastric cancer (Q36905898) (← links)
• Maternal embryonic leucine zipper kinase (MELK) reduces replication stress in glioblastoma cells (Q37099799) (← links)
• MELK: a potential novel therapeutic target for TNBC and other aggressive malignancies. (Q38648606) (← links)
• Methoxyamine Enhances 5-Fluorouracil-Induced Radiosensitization in Colon Cancer Cell Line HT29. (Q38698305) (← links)
• MELK expression in ovarian cancer correlates with poor outcome and its inhibition by OTSSP167 abrogates proliferation and viability of ovarian cancer cells (Q38715935) (← links)
• Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor (Q38790859) (← links)
• Down-regulation of BAX gene during carcinogenesis and acquisition of resistance to 5-FU in colorectal cancer (Q39079636) (← links)
• MELK is not necessary for the proliferation of basal-like breast cancer cells (Q41705554) (← links)
• CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials (Q42108657) (← links)
• Up-Regulated Maternal Embryonic Leucine Zipper Kinase Predicts Poor Prognosis of Hepatocellular Carcinoma Patients in a Chinese Han Population. (Q47153156) (← links)
• The microRNA expression signature of small cell lung cancer: tumor suppressors of miR-27a-5p and miR-34b-3p and their targeted oncogenes. (Q48147735) (← links)
• Transcription factors as master regulator for cancer stemness: remove milk from fox? (Q48663024) (← links)
• MELK expression correlates with tumor mitotic activity but is not required for cancer growth. (Q49701324) (← links)
• Challenges in validating candidate therapeutic targets in cancer. (Q50123858) (← links)
• Sanguinarine triggers intrinsic apoptosis to suppress colorectal cancer growth through disassociation between STRAP and MELK. (Q54978638) (← links)
• SATB family chromatin organizers as master regulators of tumor progression (Q58568978) (← links)
• Maternal embryonic leucine zipper kinase: A novel biomarker and a potential therapeutic target of cervical cancer (Q58593899) (← links)
• Inhibition of maternal embryonic leucine zipper kinase with OTSSP167 displays potent anti-leukemic effects in chronic lymphocytic leukemia (Q89082194) (← links)
• Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma (Q91329661) (← links)
• MELK is Upregulated in Advanced Clear Cell Renal Cell Carcinoma and Promotes Disease Progression by Phosphorylating PRAS40 (Q91779054) (← links)
• Integrated Analysis To Identify Molecular Biomarkers Of High-Grade Serous Ovarian Cancer (Q91828766) (← links)
• Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1 (Q92465189) (← links)
• Upregulated MELK Leads to Doxorubicin Chemoresistance and M2 Macrophage Polarization via the miR-34a/JAK2/STAT3 Pathway in Uterine Leiomyosarcoma (Q94546919) (← links)